Mural Oncology plc Ordinary Shares

Go to Mural Oncology plc Ordinary Shares Website

$1.82

0.04 (2.25%)
Live
Previous Close

$1.78

Day Range

$1.74 - $1.84

Previous Day Range

$1.73 - $1.84

Market Cap

$30.7 million USD

Day Vol.

141641

Previous Day Vol.

250307

Currency

USD

Primary Exchange

None

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Mural Oncology announced the complete discontinuation of all clinical programs, including its lead drug nemvaleukin alfa, and is now exploring strategic alternatives like sale or liquidation after experiencing significant financial losses.

Related tickers: MURA.

Read Full Article

Mural Oncology, a clinical-stage immuno-oncology company, announces plans to discontinue all clinical development of nemvaleukin following review of data from phase 2 and 3 trials. The company will explore strategic alternatives.

Related tickers: MURA.

Read Full Article
Trending Tickers

Please sign in to view